首页> 美国卫生研究院文献>Pharmaceutics >Optimization of Rheological Behaviour and Skin Penetration of Thermogelling Emulsions with Enhanced Substantivity for Potential Application in Treatment of Chronic Skin Diseases
【2h】

Optimization of Rheological Behaviour and Skin Penetration of Thermogelling Emulsions with Enhanced Substantivity for Potential Application in Treatment of Chronic Skin Diseases

机译:增强直接性的热凝胶乳液的流变行为和皮肤渗透性优化可潜在地用于治疗慢性皮肤病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Topical formulations are an important pillar in the therapy of skin diseases. Nevertheless, after application the formulation will be exposed to environmental effects. Contact with other surfaces will reduce the available amount of formulation and drug substance. The resulting consequences for therapy range from reduced effects to therapeutic failure. The removed active ingredient also contaminates patients’ environment. The aim of this work was to develop preparations that remain at the application site. These will enhance safety and efficiency and thus improve of skin disease therapies. Therefore, we developed polymer-stabilised emulsions that show thermogelling properties. Emulsions with different methyl cellulose concentrations and macrogols of different molecular weights were investigated. The dispersed phase consisted of nonivamide as the active pharmaceutical ingredient, dissolved in medium-chain triglycerides. Rheological properties, droplet size, substantivity and ex vivo penetration experiments were performed to characterise the developed formulations. Droplet size and rheological parameters were affected by the composition of the preparations. The tested formulations showed benefits in their substantivity compared to a conventional semi-solid cream. We found a residual amount of up to 100% at the application site. The drug levels in viable epidermis were in a therapeutic range. The developed emulsions are a promising vehicle to improve therapy for chronic skin diseases.
机译:局部用制剂是治疗皮肤疾病的重要支柱。然而,在施用后,该制剂将暴露于环境影响。与其他表面接触会减少制剂和原料药的可用量。对治疗产生的后果范围从降低的效果到治疗失败。去除的活性成分还会污染患者的环境。这项工作的目的是开发保留在应用程序现场的准备工作。这些将提高安全性和效率,从而改善皮肤疾病的治疗方法。因此,我们开发了具有热胶凝性能的聚合物稳定乳液。研究了具有不同甲基纤维素浓度和不同分子量的大分子乳液。分散相由壬毒酰胺作为活性药物成分组成,溶于中链甘油三酸酯。进行流变学性质,液滴尺寸,直接性和离体渗透实验以表征开发的制剂。液滴的大小和流变参数受制剂组成的影响。与常规的半固体霜剂相比,测试的制剂在其直接性方面显示出益处。我们发现应用程序站点中的残留量高达100%。活表皮中的药物水平在治疗范围内。研发的乳液是改善慢性皮肤疾病治疗的有前途的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号